Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centene Corp (CNC) vs Uranium Energy Corp (UEC) Price & Performance

Centene CorpTrade
Uranium Energy CorpTrade

Price performance (Past 24H)

Key statistics

Centene Corp vs Uranium Energy Corp — how do they compare? Centene Corp trades at $65.58 (market cap $32.89B), while Uranium Energy Corp trades at $11.49 (market cap $5.63B). The key difference: Centene Corp is far larger — about 5.8× Uranium Energy Corp's market cap, and Centene Corp is trading nearer its 52-week high, Uranium Energy Corp nearer its low. Which is the better fit depends on your goals.

CNCUEC
Market Cap
$32.89B$5.63B
Sector
HealthEnergy
52-Week High
$68.72$20.14
52-Week Low
$26.17$9.04
Enterprise Value
$21.93B$5.14B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Centene Corp

Centene (CNC) trades at $65.77, up 2.48% with a bullish technical signal. Recent Q2 2026 earnings beat expectations with EPS of $2.51 versus $1.09 estimate, driven by margin recovery and cost control. Revenue grew to $194.78B in 2025, though net income was negative at -$6.67B. Valuation ratios are attractive with P/E of 8.06 and P/S of 0.16. Analyst consensus is strongly bullish with 61.37% buy ratings and a $70.36 price target.

Outlook is positive due to raised 2026 guidance and operational improvements, but risks include Medicaid membership softness and persistent negative margins. The stock offers value potential if profitability rebounds as projected, though investors should monitor medical cost trends and regulatory changes affecting government healthcare programs.

Uranium Energy Corp

UEC trades at $11.26, up 4.65% in the last 24 hours, with a bullish technical signal from moving averages. The company reported a net loss of $87.66 million in 2025, with revenue of $66.84 million, and faces profitability challenges with a negative net income margin of -513.24%. Recent news highlights optimism around nuclear energy growth, but financial performance remains under pressure.

Outlook is mixed: strong analyst buy ratings (87.5%) and sector tailwinds support potential, but persistent losses, high P/S ratio of 265.97, and execution risks pose significant challenges. Investors should weigh the speculative growth narrative against fundamental weaknesses and cash flow concerns.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC

About Uranium Energy Corp

Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.

Read more on UEC